BamSEC and AlphaSense Join Forces
Learn More

Enanta Pharmaceuticals Inc.

NASDAQ: ENTA    
Share price (12/26/24): $6.00    
Market cap (12/26/24): $127 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.2
from 8-K 20 pages Amended and Restated Bylaws of Enanta Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 22 pages Amended and Restated Bylaws of Enanta Pharmaceuticals, Inc
12/34/56
EX-3.4
from 8-K 51 pages Sixth Amended and Restated Certificate of Incorporation of Enanta Pharmaceuticals, Inc. Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.3
from 8-K 3 pages Certificate of Retirement of Series a Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock, Series D Convertible Preferred Stock, Series E Convertible Preferred Stock, Series F Convertible Preferred Stock, Series G-1 Convertible Preferred Stock and Series G-2 Convertible Preferred Stock of Enanta Pharmaceuticals, Inc
12/34/56
EX-3.2
from 8-K 17 pages Amended and Restated Bylaws of Enanta Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 16 pages Restated Certificate of Incorporation of Enanta Pharmaceuticals, Inc
12/34/56
EX-3.5
from S-1/A 17 pages Amended and Restated Bylaws of Enanta Pharmaceuticals, Inc
12/34/56
EX-3.4
from S-1/A 16 pages Restated Certificate of Incorporation of Enanta Pharmaceuticals, Inc
12/34/56
EX-3.3
from S-1/A 3 pages Certificate of Amendment to Fifth Amended and Restated Certificate of Incorporation of Enanta Pharmaceuticals, Inc
12/34/56
EX-3.2
from S-1 11 pages By-Laws of Enanta Pharmaceuticals, Inc
12/34/56
EX-3.1
from S-1 46 pages Fifth Amended and Restated Certificate of Incorporation of Enanta Pharmaceuticals, Inc. Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56